Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...

This study presents an enhanced nuclease prime editor (uPEn) that significantly improves gene knock-in and knockout ...

Exploration of dsRNA interactome using the K1 antibody and functional studies using CRISPR-Cas9 knockout screening of these dsRBP candidates elucidate the role of dsRNA interactome in immune ...

Scientists have identified the 1N4R tau isoform as a key driver of Alzheimer’s disease, paving the way for potential new ...

Cornell University researchers have discovered a new mechanism these genes use to survive and propagate in bacteria with ...

Crispr Therapeutics AG reported significant ... inhibition of multiple CAR T cell functions. 6.For CTX131 only, knock-out of CD70 to prevent CAR T cells from killing other CAR T cells and further ...

DNA segments that can move from one part of the genome to another -- are key to bacterial evolution and the development of antibiotic resistance. Researchers have discovered a new mechanism these ...

Researchers have identified a specific form of the tau protein that is responsible for mediating the toxicity of harmful protein clumps in human neurons and thus represents a target for future treatme ...

DNA segments that can move from one part of the genome to another – are key to bacterial evolution and the development of ...

A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein in Alzheimer's disease.

Scientists from the University of Cologne identified the 1N4R tau isoform as a key contributor to neuronal dysfunction in ...

Transposons have been found clustered at the chromosome ends in eukaryotic cells, but this is the first time it's been ...